Logo image of BLCO.CA

BAUSCH + LOMB CORP (BLCO.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:BLCO - CA0717051076 - Common Stock

22.54 CAD
-0.2 (-0.88%)
Last: 11/27/2025, 7:00:00 PM
Fundamental Rating

4

Overall BLCO gets a fundamental rating of 4 out of 10. We evaluated BLCO against 18 industry peers in the Health Care Equipment & Supplies industry. BLCO has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLCO has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BLCO was profitable.
BLCO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BLCO reported negative net income in multiple years.
Of the past 5 years BLCO 4 years had a positive operating cash flow.
BLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFBLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

With an excellent Return On Assets value of -2.21%, BLCO belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of -4.74%, BLCO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 0.69%, BLCO belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
BLCO had an Average Return On Invested Capital over the past 3 years of 1.45%. This is in line with the industry average of 0.69%.
Industry RankSector Rank
ROA -2.21%
ROE -4.74%
ROIC 0.69%
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
BLCO.CA Yearly ROA, ROE, ROICBLCO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4

1.3 Margins

The Operating Margin of BLCO (2.31%) is better than 100.00% of its industry peers.
BLCO's Operating Margin has declined in the last couple of years.
The Gross Margin of BLCO (59.45%) is better than 61.11% of its industry peers.
BLCO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.31%
PM (TTM) N/A
GM 59.45%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
BLCO.CA Yearly Profit, Operating, Gross MarginsBLCO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLCO is destroying value.
BLCO has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BLCO has been increased compared to 5 years ago.
The debt/assets ratio for BLCO is higher compared to a year ago.
BLCO.CA Yearly Shares OutstandingBLCO.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
BLCO.CA Yearly Total Debt VS Total AssetsBLCO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 0.85, we must say that BLCO is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.85, BLCO belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
BLCO has a Debt/Equity ratio of 0.77. This is a neutral value indicating BLCO is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.77, BLCO is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Altman-Z 0.85
ROIC/WACC0.1
WACC7.26%
BLCO.CA Yearly LT Debt VS Equity VS FCFBLCO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

BLCO has a Current Ratio of 1.51. This is a normal value and indicates that BLCO is financially healthy and should not expect problems in meeting its short term obligations.
BLCO has a Current ratio of 1.51. This is in the better half of the industry: BLCO outperforms 77.78% of its industry peers.
BLCO has a Quick Ratio of 1.51. This is a bad value and indicates that BLCO is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.98, BLCO is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 0.98
BLCO.CA Yearly Current Assets VS Current LiabilitesBLCO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

The earnings per share for BLCO have decreased strongly by -29.51% in the last year.
Looking at the last year, BLCO shows a small growth in Revenue. The Revenue has grown by 6.23% in the last year.
BLCO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.87% yearly.
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%

3.2 Future

BLCO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.18% yearly.
Based on estimates for the next years, BLCO will show a small growth in Revenue. The Revenue will grow by 4.94% on average per year.
EPS Next Y-11.58%
EPS Next 2Y12.93%
EPS Next 3Y18.02%
EPS Next 5Y24.18%
Revenue Next Year6.52%
Revenue Next 2Y6.16%
Revenue Next 3Y5.72%
Revenue Next 5Y4.94%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BLCO.CA Yearly Revenue VS EstimatesBLCO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
BLCO.CA Yearly EPS VS EstimatesBLCO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 36.95 indicates a quite expensive valuation of BLCO.
100.00% of the companies in the same industry are more expensive than BLCO, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of BLCO to the average of the S&P500 Index (26.15), we can say BLCO is valued slightly more expensively.
The Price/Forward Earnings ratio is 20.24, which indicates a rather expensive current valuation of BLCO.
BLCO's Price/Forward Earnings ratio is rather cheap when compared to the industry. BLCO is cheaper than 94.44% of the companies in the same industry.
BLCO is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 36.95
Fwd PE 20.24
BLCO.CA Price Earnings VS Forward Price EarningsBLCO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BLCO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BLCO is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.07
BLCO.CA Per share dataBLCO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The decent profitability rating of BLCO may justify a higher PE ratio.
A more expensive valuation may be justified as BLCO's earnings are expected to grow with 18.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.93%
EPS Next 3Y18.02%

0

5. Dividend

5.1 Amount

BLCO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BAUSCH + LOMB CORP

TSX:BLCO (11/27/2025, 7:00:00 PM)

22.54

-0.2 (-0.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-13 2026-02-13/bmo
Inst Owners11.05%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap7.98B
Revenue(TTM)4.98B
Net Income(TTM)-305.00M
Analysts72
Price Target23.74 (5.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.13%
Min EPS beat(2)1.79%
Max EPS beat(2)8.47%
EPS beat(4)3
Avg EPS beat(4)-86.5%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)6
Avg EPS beat(8)-37.66%
EPS beat(12)9
Avg EPS beat(12)-24.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.15%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.39%
Revenue beat(4)0
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.16%
Revenue beat(8)3
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)0.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.31%
PT rev (3m)8.97%
EPS NQ rev (1m)-2.59%
EPS NQ rev (3m)-2.92%
EPS NY rev (1m)1.62%
EPS NY rev (3m)1.09%
Revenue NQ rev (1m)-0.63%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-0.13%
Valuation
Industry RankSector Rank
PE 36.95
Fwd PE 20.24
P/S 1.14
P/FCF N/A
P/OCF 33.52
P/B 0.88
P/tB N/A
EV/EBITDA 19.07
EPS(TTM)0.61
EY2.71%
EPS(NY)1.11
Fwd EY4.94%
FCF(TTM)-0.78
FCFYN/A
OCF(TTM)0.67
OCFY2.98%
SpS19.8
BVpS25.58
TBVpS-6.19
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.74
Profitability
Industry RankSector Rank
ROA -2.21%
ROE -4.74%
ROCE 0.96%
ROIC 0.69%
ROICexc 0.71%
ROICexgc 2.27%
OM 2.31%
PM (TTM) N/A
GM 59.45%
FCFM N/A
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
ROICexc(3y)1.5%
ROICexc(5y)1.8%
ROICexgc(3y)4.98%
ROICexgc(5y)6.16%
ROCE(3y)2.02%
ROCE(5y)2.43%
ROICexgc growth 3Y-21.86%
ROICexgc growth 5Y-17.06%
ROICexc growth 3Y-20.45%
ROICexc growth 5Y-15.79%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Debt/EBITDA 9.06
Cap/Depr 85.28%
Cap/Sales 7.34%
Interest Coverage 250
Cash Conversion 31.12%
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 0.98
Altman-Z 0.85
F-Score4
WACC7.26%
ROIC/WACC0.1
Cap/Depr(3y)53.43%
Cap/Depr(5y)52.81%
Cap/Sales(3y)5.03%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
EPS Next Y-11.58%
EPS Next 2Y12.93%
EPS Next 3Y18.02%
EPS Next 5Y24.18%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
Revenue Next Year6.52%
Revenue Next 2Y6.16%
Revenue Next 3Y5.72%
Revenue Next 5Y4.94%
EBIT growth 1Y-39.47%
EBIT growth 3Y-15.55%
EBIT growth 5Y-13.93%
EBIT Next Year45.28%
EBIT Next 3Y21.2%
EBIT Next 5Y15.82%
FCF growth 1Y-880%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.07%
OCF growth 3Y-35.71%
OCF growth 5Y-21.91%

BAUSCH + LOMB CORP / BLCO.CA FAQ

What is the fundamental rating for BLCO stock?

ChartMill assigns a fundamental rating of 4 / 10 to BLCO.CA.


What is the valuation status for BLCO stock?

ChartMill assigns a valuation rating of 4 / 10 to BAUSCH + LOMB CORP (BLCO.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for BAUSCH + LOMB CORP?

BAUSCH + LOMB CORP (BLCO.CA) has a profitability rating of 6 / 10.


What is the valuation of BAUSCH + LOMB CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BAUSCH + LOMB CORP (BLCO.CA) is 36.95 and the Price/Book (PB) ratio is 0.88.


Can you provide the financial health for BLCO stock?

The financial health rating of BAUSCH + LOMB CORP (BLCO.CA) is 3 / 10.